Novartis Korea to register Certican, an immuno-suppressant.
Certican is a proliferation signal inhibitor for the prophylaxis of organ rejection in heart and kidney transplant patients who are in moderate and severe immunological risk, which can be use...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
